Pharmotips Healthcare Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
- Paid Up Capital ₹ 6.95 M
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 2.71%
- Profit Growth -5.72%
- Ebitda -3.20%
- Net Worth 8.56%
- Total Assets 114.33%
About Pharmotips Healthcare
Pharmotips Healthcare Private Limited (PHPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 28 February 2011 and has a history of 13 years and 11 months. Its registered office is in Thane, Maharashtra, India.
The Corporate was formerly known as Amnon Healthcare Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.95 M, as per Ministry of Corporate Affairs (MCA) records.
Noman Ansari, Saleemakhtar Ansari, and Mohd Ansari serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24249MH2011PTC214120
- Company No.
214120
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Pharmotips Healthcare?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Noman Ansari  | Director | 28-Feb-2011 | Current |
| Saleemakhtar Ansari | Director | 28-Feb-2011 | Current |
| Mohd Ansari | Director | 08-Nov-2021 | Current |
Financial Performance of Pharmotips Healthcare.
Pharmotips Healthcare Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.71% increase. The company also saw a slight decrease in profitability, with a 5.72% decrease in profit. The company's net worth moved up by a moderate rise of 8.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmotips Healthcare?
In 2023, Pharmotips Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmotips Healthcare?
Unlock and access historical data on people associated with Pharmotips Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmotips Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmotips Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
